Patent Assignment
Reel/Frame 015190/0205
Assignment of Assignor's Interest
Recorded: 2004-09-28
Pages: 6
Assignor
ELAN PHARMACEUTICALS, INC.
Executed: 2004-03-31
Assignee
XCEL PHARMACEUTICALS, INC.
7475 LUSK BLVD., SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Rectally-Administered, Epileptic-Seizure-Inhibiting Composition
Patent:
5,462,740 →
Application:
08/122,685 →
Related Assignments
(15)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 26, 1994
From: EVENSTAD, KENNETH L.; O'NEILL, VICTORIA A.; GORHAM, THOMAS R.
To: UPSHER-SMITH LABORATORIES, INC.
Reel/Frame 006962/0608 →
Assignment of Assignor's Interest
Apr 26, 1994
From: UPSNER-SMITH LABORATORIES, INC.
To: ATHENA NEUROSCIENCES, INC.
Reel/Frame 006962/0605 →
Assignment of Assignor's Interest
Mar 29, 1999
From: ATHENA NEUROSCIENCES, INC.
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 009852/0078 →
Assignment of Assignor's Interest
Apr 9, 2001
From: ELAN PHARMACEUTICALS, INC.
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 011648/0004 →
Security Interest
Jun 22, 2001
From: XCEL PHARMACEUTICALS, INC.
To: ELAN PHARMA INTERNATIONAL LIMITED
Reel/Frame 011911/0642 →
Security Interest
Apr 2, 2003
From: XOEL PHARMACEUTICALS, INC.
To: REGIMENT CAPITAL III, L.P.
Reel/Frame 013897/0194 →
Termination of Security Interest
Apr 2, 2003
From: ELAN PHARMA INTERNATIONAL LIMITED
To: XCEL PHARMACEUTICALS INC.
Reel/Frame 013887/0900 →
Corrective Coversheet to Correct the Execution Date That Was Previously Recorded on Reel 015190, Frame 0205.
Oct 4, 2004
From: ELAN PHARMACEUTICALS, INC.
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 015215/0277 →
Release of Security Agreement
Mar 7, 2005
From: REGIMENT CAPITAL III, L.P.
To: XCEL PHARMACEUTICALS, INC.
Reel/Frame 015732/0626 →
Change of Name
Apr 8, 2005
From: XCEL PHARMACEUTICALS, INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 016097/0609 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →
Security Agreement
Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →